Search


 
Results 11 - 20 of about 80 for "FDA update".

Warning on DPP-4 inhibitors and insulin recall | ACP Diabetes ...

Dipeptidyl peptidase-4 (DPP-4) inhibitors may cause joint pain that can be severe and disabling, and some insulin pods may fail, the FDA recently warned ...

New GLP-1 agonist approved | ACP Diabetes Monthly

A new glucagon-like peptide-1 (GLP-1) receptor agonist, dulaglutide (Trulicity), was approved to treat type 2 diabetes, along with diet and exercise, the ...

SGLT2 inhibitors associated with ketoacidosis | ACP Diabetes ...

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, including canagliflozin, dapagliflozin, and empagliflozin, may cause ketoacidosis, the FDA recently ...

Glucose monitoring system approved specifically for critical ...

The FDA recently approved a new indication for the Nova StatStrip Glucose Hospital Meter System, extending its use to critically ill patients who have ...

New weight loss device approved | ACP Diabetes Monthly

A new balloon device (the ReShape Dual Balloon) was recently approved by the FDA to treat obesity without invasive surgery.

Warning on risks of canagliflozin | ACP Diabetes Monthly

The FDA on Sept. 10 released a strengthened warning on canagliflozin (Invokana, Invokamet) about increased risk of bone fractures and decreased ...

New long-acting insulin drugs approved | ACP Diabetes ...

Insulin degludec injection (Tresiba) and insulin degludec/insulin aspart injection (Ryzodeg 70/30) were approved by the FDA on Sept. 25.

New labels warn against sharing multi-dose insulin pens ...

In an effort to reduce the risk of infection spread, the FDA recently required additional label warnings about sharing of multi-dose diabetes pen devices ...

First drug in new class approved | ACP Diabetes Monthly

The FDA recently approved canaglifozin (Invokana) tablets to improve glycemic control in adults with type 2 diabetes, along with diet and exercise.

July 11, 2014 | ACP Diabetes Monthly

... FDA update. Inhaled insulin approved. Afrezza, a rapid-acting, inhaled human insulin, was recently approved by the FDA to treat diabetes in adults. ...

Result Page: < Previous  1 2 3 4 5 6  Next >